source
- Kali Therapeutics pivots from Chinese drug acquisitions to focus on its own growing pipelineKali Therapeutics, the winner of the Endpoints 11 2026 competition, initially explored the possibility of purchasing drug candidates from China. The company ultimately chose to rely on its own res…
- Stipple Bio wins Endpoints 2026 award for precision pancreatic cancer therapyStipple Bio was announced as the winner of the Endpoints 2026 competition, recognized for its work in precision medicine. The company’s approach focuses on developing targeted treatments for pancr…